On January 13, 2025, the Stochastic Oscillator for AXON moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 61 instances where the indicator left the oversold zone. In of the 61 cases the stock moved higher in the following days. This puts the odds of a move higher at over .
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where AXON's RSI Oscillator exited the oversold zone, of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AXON advanced for three days, in of 379 cases, the price rose further within the following month. The odds of a continued upward trend are .
AXON may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
AXON moved below its 50-day moving average on January 06, 2025 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for AXON crossed bearishly below the 50-day moving average on January 10, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXON declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for AXON entered a downward trend on January 14, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 69, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AXON’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (22.075) is normal, around the industry mean (9.311). AXON has a moderately high P/E Ratio (157.818) as compared to the industry average of (61.778). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.355). AXON has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (24.213) is also within normal values, averaging (8.071).
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
a clinical-stage biopharmaceutical company
Industry AerospaceDefense
A.I.dvisor tells us that AXON and AIR have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AXON and AIR's prices will move in lockstep.
Ticker / NAME | Correlation To AXON | 1D Price Change % | ||
---|---|---|---|---|
AXON | 100% | +1.97% | ||
AIR - AXON | 30% Poorly correlated | +2.85% | ||
CMGMF - AXON | 30% Poorly correlated | N/A | ||
DRS - AXON | 30% Poorly correlated | +3.17% | ||
CAE - AXON | 27% Poorly correlated | +2.11% | ||
HWM - AXON | 27% Poorly correlated | +1.48% | ||
More |